Memorial Sloan-Kettering Cancer Center's Cycle for Survival, www.cycleforsurvival.org, is coming to New York on February 12th and 13th.
Cycle for Survival is an indoor cycling fundraiser benefiting research for rare cancers -- forms of the disease that are uncommon and lack the funding necessary for advancements in treatment. Research that helps these rare forms of the disease also help better funded and prevalent cancers such as lung, breast, prostate and colon. A full 100% of the monies raised from the January 25th event will benefit rare cancer research.
Founded in 2007 by patient Jennifer Goodman Linn (formerly named Spin4Survival), the initiative has raised more than $800,000 in support of pioneering research for rare cancers at Memorial Sloan-Kettering. These funds have already made an impact by supporting clinical trials that have led to new chemotherapy regimens used to treat lesser-known forms of this deadly disease. This treatment was in fact used to treat Jennifer Goodman Linn during her second battle with cancer.
"Each rare cancer affects fewer than 200,000 individuals," said Dr. Robert Maki, associate attending physician and co-director of the Adult Sarcoma Program in Memorial Sloan-Kettering's Department of Medicine. "Rare cancers are frustratingly difficult to diagnose and treat. In aggregate, they have a profound impact on the lives of our patients and their families. Cycle for Survival underscores our steadfast commitment to finding new ways to fight cancer in all its forms."
Cyclists can use the secure site cycleforsurvival.org to register to ride for a team. Contributions can also be made on online.
